Cite

HARVARD Citation

    Elalfy, H. et al. (2019). Clinicopathological impact of anti-smooth muscle antibodies in patients with non-alcoholic fatty liver disease. British journal of biomedical science. 76 (2), pp. 101-103. [Online]. 
  
Back to record